...
首页> 外文期刊>american journal of clinical and experimental urology >A case report of mucinous tubular and spindle cell carcinoma of the kidney
【24h】

A case report of mucinous tubular and spindle cell carcinoma of the kidney

机译:肾粘液性肾小管癌和梭形细胞癌的病例报告

获取原文
获取原文并翻译 | 示例

摘要

Mucinous tubular and spindle cell carcinoma (MTSCC) is a rare type of kidney tumor that has only re-cently been described, with less than eighty cases in the literature. This was only recognized as a specific entity in the World Health Organization 2004 classification of Renal Cell Carcinoma (RCC). MTSCCs are polymorphic renal neoplasms characterized by small, elongated tubules lined by cuboidal cells with cords of spindled cells separated by pale mucinous stroma. We report the case of a 57 year old lady who had an incidental finding of a mass in her right kidney. The radiological features were consistent with a RCC and following a multidisciplinary team discussion she underwent a laparoscopic radical nephrectomy. Macroscopic examination revealed a well circumscribed 6.5 x 6 x 6.5 cm right lower pole mass. Histologically it was composed of elongated tubules, small tubules and papillary structures with a necrotic centre. The cells demonstrated cuboidal and spindle cell morphology. Histological grade was Fuhrman grade 2. The majority of MTSCCs are indolent, and there are only two reports of distant metastases which responded favorably to adjuvant sunitinib. To date there is no international consensus on long term surveil-lance of these patients. Due of the favorable prognosis with this type of tumor, MTSCC must be differentiated from papillary renal cell carcinoma to avoid administration of excessive adjuvant treatment to patients.
机译:粘液性肾小管和梭形细胞癌 (MTSCC) 是一种罕见的肾肿瘤类型,最近才被重新描述,文献中不到 80 例。这仅在世界卫生组织 2004 年肾细胞癌 (RCC) 分类中被认可为特定实体。MTSCCs是多形性肾肿瘤,其特征是小而细长的小管,由立方体细胞衬里,梭形细胞索由苍白的粘液基质隔开。我们报告了一位 57 岁女士的病例,她偶然发现右肾有肿块。放射学特征与 RCC 一致,经过多学科团队讨论后,她接受了腹腔镜根治性肾切除术。肉眼检查显示右下极质量呈 6.5 x 6 x 6.5 cm 的边界良好。在组织学上,它由细长的小管、小管和具有坏死中心的状结构组成。细胞表现出立方体和梭形细胞形态。组织学分级为 Fuhrman 2 级。大多数MTSCCs是惰性的,只有两例远处转移的报道对舒尼替尼辅助治疗反应良好。迄今为止,国际上尚未就这些患者的长期监测达成共识。由于这种肿瘤的预后良好,必须将MTSCC与状肾细胞癌区分开来,以避免对患者进行过度的辅助治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号